Clinical trial
Therapeutic Effect of Granulocytapheresis in Psoriasis (GRIP-study)Using a Novel Cellulose-based Adsorber Device
NCT00714272 is registered in ClinicalTrials.gov with EXcorLab GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Therapeutic Effect of Granulocytapheresis in Psoriasis (GRIP-study)Using a Novel Cellulose-based Adsorber Device
- Lead sponsor
- EXcorLab GmbH
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- February 18, 2008
- Completion date
- January 31, 2009
- Enrollment
- 4 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.